<DOC>
	<DOCNO>NCT01879514</DOCNO>
	<brief_summary>IgA nephropathy ( IgAN ) high incidence kidney pathology primary nephropathy . In term difference prognosis , severe IgA nephropathy , one main primary renal disease , could cause uremia . It significant early indicator prognosis early intervention normalize scientific criterion judge efficacy great clinical establish . The subject base past study , literature research various treatment take method multi-center , double-blind , randomize , control investigate standard treatment severe IgA nephropathy . Otherwise uniformity objectivity Traditional Chinese Medicine ( TCM ) improve standardization TCM research base epidemiological investigation statistical analysis . The subject determine efficacy sensitive biomarkers establish scientific criterion judge effect application urine proteomics metabolomics technology order operate formation standardization program treatment severe IgA nephropathy Integrative medicine TCM .</brief_summary>
	<brief_title>Study Standardized Treatment Integrative Medicine With Severe IgA Nephropath</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , IGA</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Confirmed renal biopsy clinical examination primary IgA nephropathy . Pathology : upon Lee 's grade Ⅲ Age :1860 year old . Gender nationality limit Chronic Kidney Disease ( CKD ) Stage 3 : （59 ml/min＞GFR＞30ml/min/1.73m2） 24hour urine protein : ≥1.0g.Informed consent Patients within past 3 month receive immunosuppressive agent cytotoxic therapy great 4 week Patients within past 3 month receive corticosteroid ( prednisone prednisolone ) dose 20mg / 4 week Patients suffer acute rapidly progressive glomerulonephritis Patients continue active hepatitis B abnormal liver function test transaminase Patients history malignant tumor malignancy , HIV infection , history mental illness , acute central nervous system disorder , severe gastrointestinal disease , prohibit use immunosuppressive agent Abnormal glucose metabolism , fast blood glucose 6.2mmol/L Pregnancy breastfeed woman Receiving clinical trial Associated serious disease organ dysfunction Combined lifethreatening complication severe infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>IgA nephropathy</keyword>
	<keyword>Therapy Chinese medicine</keyword>
</DOC>